Intravenous Immunoglobulin Market to Expand at a CAGR of 8.5% During 2017-2024
The global Intravenous Immunoglobulin (IVIG) Market is largely consolidated, with top four players: Grifols S.A., CSL Behring LLC, Baxalta Incorporated, and Octapharma AG, accounting for more than two-third of the total shares as of 2017. Among these, Grifols S.A. accounted for the dominant share on account of the company's strong geographic penetration.
View full press release